Skip to content
BALCAO · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES · SMALL CAP

ENvue Medical, Inc. FEED

12 fiscal years on record · USD · FY2025 reported · SEC filings only
$2.6M
▼ 0.2% YoY
$-18.2M
$-9.4M

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Growth

USD 2.6M
Revenue, FY2025 · full 12-year series below
Revenue $M Net income $M
FY2025 · Revenue 2.6 · Net income -18.2
1M2M-10M-20M
20142017202020232025
Compound annual growth
+50.3%
+32.6%
+33.0%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +32.6% a year over the five years to FY2025.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

−712 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -896.6% · Net -712.3%
-500%-1000%
201420192025
ROE
FY2025 · ROE -106.6%
-200%-400%-600%
201420192025
Three returns, three denominators.

Each USD of equity lost 107 cents this year.

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -9.4
-4M-8M
201420192025

Total assetsUSD 41.1M
EquityUSD 33.5M
CashUSD 4.2M
Current ratio1.09×

Equity funds 81% of total assets.

The 12-year record

12 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
FEED, 12-year financial record
Metric 202520242023202220212020201920182017201620152014
Revenue $B0.00.00.00.00.00.00.00.00.00.00.00.0
Operating income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EBITDA $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
Income tax $B−0.00.00.00.00.00.0−0.0−0.00.00.00.00.0
Net income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
Free cash flow $B−0.0−0.0−0.0−0.0−0.0−0.0◌−0.0◌−0.0−0.0−0.0
EPS, diluted $−26.69−137.30−23.32−3.84−0.57−0.42−0.83−0.64−1.17−0.62−0.82−17.08
Dividend / sh $◌◌◌◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend————————————
ROE %−106.6−160.5−102.8−114.1−328.1−231.3−640.2−202.8————
Shares out B0.000.000.000.000.030.020.000.000.000.000.000.00

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 60 reconciliationsAUDITED

Reconciled in 12 of the 12 fiscal years we could check. 14 checks were skipped: the balance sheet is not tagged before 2014. Seven checks were skipped: EPS is not tagged before 2014. Seven checks were skipped: revenue is not tagged before 2014.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityOrthopedic, Prosthetic & Surgical Appliances & Supplies
Listed onOTC market
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2014

Share this section

Download image